TIMNF yields 2000000.00% · JNJ yields 2.14%● Live data
📍 TIMNF pulled ahead of the other in Year 1
Combined, TIMNF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TIMNF + JNJ for your $10,000?
Timminco Limited, together with its subsidiaries, produces and sells silicon metal and solar grade silicon products for electronics, chemical, aluminum, and solar industries. It offers chemical grade silicon metal for use in the application of various consumer products, such as sealants, rubber, fluids, lubricants, textiles, and cosmetics; electronics grade silicon metal for use in electronics, including computer chip wafers, semiconductors, solar cells, and fiber optic cables, as well as in pharmaceutical substrates and tires; and aluminum grade silicon metal for use as an alloying agent in aluminum primarily used for automobile components. The company also provides other silicon metal products comprising silica fumes used as an ingredient in cement for marine structures or bridge foundations, and as a thermal insulator; and dross and silicon-containing slags used in iron foundries/steel industries. In addition, it offers a patented metallurgical-based process to purify silicon metal into solar grade silicon for the manufacture of wafers and cells for solar energy systems. Timminco Limited was founded in 1934 and is based in Toronto, Canada.
Full TIMNF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.